Abstract |
Diarylquinoline compounds are newly synthesized derivatives of the new anti-tuberculosis drug, TMC207. In this study, nine diarylquinoline compounds were screened for cytotoxic activity against human tumor cells, and their mechanisms of action were investigated. Among the nine compounds, STM-57 [N-((6-bromo-2-methoxyquinolin-3-yl)(phenyl)methl)-N-(3,4-dichlorophenyl)-3-(4 -methylpiperazin-1-yl)propanamide] showed potent cytotoxic activity. STM-57 induced caspase-independent cell death in the human nasopharyngeal carcinoma cell line, CNE-2. Further investigation showed that STM-57 induced autophagy, as determined with the increased expression of green fluorescent protein-light chain 3 (GFP-LC3) and increased LC3-II levels. STM-57 inhibited the phosphorylation of Akt and the mammalian target of rapamycin (mTOR) in CNE-2 cells. The intracellular calcium concentration and reactive oxygen species levels were increased in CNE-2 cells following treatment with STM-57, whereas the mitochondrial transmembrane potential (ΔΨm) and ATP concentrations were decreased.
|
Authors | Yuchen Cai, Zhihui Wan, Tiemin Sun, Yanxia Shi, Yueli Sun, Peiyu Huang, Su Li, Wenqi Jiang |
Journal | Oncology reports
(Oncol Rep)
Vol. 29
Issue 3
Pg. 983-92
(Mar 2013)
ISSN: 1791-2431 [Electronic] Greece |
PMID | 23291974
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Apoptosis Regulatory Proteins
- BECN1 protein, human
- Beclin-1
- Diarylquinolines
- MAP1LC3A protein, human
- Membrane Proteins
- Microtubule-Associated Proteins
- N-((6-bromo-2-methoxyquinolin-3-yl)(phenyl)methl)-N-(3,4-dichlorophenyl)-3-(4-methylpiperazin-1-yl)propanamide
- Proto-Oncogene Proteins c-bcl-2
- Reactive Oxygen Species
- Proto-Oncogene Proteins c-akt
|
Topics |
- Antineoplastic Agents
(chemical synthesis, pharmacology)
- Apoptosis Regulatory Proteins
(metabolism)
- Autophagy
(drug effects)
- Beclin-1
- Carcinoma
- Cell Line, Tumor
- Diarylquinolines
(chemical synthesis, pharmacology)
- Drug Screening Assays, Antitumor
- G1 Phase Cell Cycle Checkpoints
(drug effects)
- Humans
- Inhibitory Concentration 50
- Membrane Potential, Mitochondrial
(drug effects)
- Membrane Proteins
(metabolism)
- Microtubule-Associated Proteins
(metabolism)
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
- Proto-Oncogene Proteins c-akt
(metabolism)
- Proto-Oncogene Proteins c-bcl-2
(metabolism)
- Reactive Oxygen Species
(metabolism)
- Signal Transduction
|